Dermata Therapeutics, Inc. (NASDAQ:DRMA – Get Free Report) was the target of a large decline in short interest in the month of January. As of January 31st, there was short interest totalling 279,400 shares, a decline of 5.5% from the January 15th total of 295,600 shares. Based on an average trading volume of 947,300 shares, […]
Dermata Therapeutics, Inc. (NASDAQ:DRMA – Get Free Report) rose 5% during mid-day trading on Thursday . The stock traded as high as $0.49 and last traded at $0.47. Approximately 111,549 shares changed hands during mid-day trading, a decline of 93% from the average daily volume of 1,531,422 shares. The stock had previously closed at $0.44. […]
Dermata Therapeutics, Inc. (NASDAQ:DRMA – Get Free Report) was the recipient of a significant decline in short interest in the month of August. As of August 15th, there was short interest totalling 14,400 shares, a decline of 10.0% from the July 31st total of 16,000 shares. Based on an average trading volume of 164,800 shares, […]
Dermata Therapeutics, Inc. (NASDAQ:DRMA – Get Free Report) shares shot up 2.7% during mid-day trading on Monday . The stock traded as high as $1.16 and last traded at $1.16. 10,027 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 1,352,323 shares. The stock had previously closed at […]
Dermata Therapeutics, Inc. (NASDAQ:DRMA – Get Free Report)’s share price was down 2% on Friday . The company traded as low as $1.49 and last traded at $1.49. Approximately 53,953 shares were traded during mid-day trading, a decline of 96% from the average daily volume of 1,501,428 shares. The stock had previously closed at $1.52. […]